Skip to main content
Fig. 2 | Trials

Fig. 2

From: Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA

Fig. 2

US FDA reviewer trial interpretation and publication, along with a published interpretation of the trial findings, for novel cardiovascular devices approved by the US FDA between 2005 and 2020, pre- and post-FDAAA. US FDA reviewer trial interpretation as positive, equivocal, or negative. A Pre-FDAAA; B Post-FDAAA

Back to article page

Trials

ISSN: 1745-6215